-
Atara Biotherapeutics (NASDAQ:ATRA) Earns Buy Rating from Analysts at Rodman & Renshaw
Source: Buzz FX / 20 Dec 2024 07:52:12 America/Chicago
Atara Biotherapeutics (NASDAQ:ATRA) Earns Buy Rating from Analysts at Rodman & Renshaw Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Rodman & Renshaw began coverage on shares of Atara Biotherapeutics ( NASDAQ:ATRA
Read more...